Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 27 Issue: 27
Author(s): Dominique Heymann
Affiliation:
Export Options
About this article
Cite this article as:
Heymann Dominique , Meet Our Editorial Board Member, Current Medicinal Chemistry 2020; 27 (27) . https://dx.doi.org/10.2174/092986732727200619162346
DOI https://dx.doi.org/10.2174/092986732727200619162346 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies A Novel Treatment Strategy for Sepsis and Septic Shock Based on the Interactions between Prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic Acid
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Hot Topic: Targeted Therapies in the Treatment of Breast Cancer and Localized Sarcomas)
Current Medicinal Chemistry May Endocrine Therapy be Associated with Cognitive Impairment in Breast Cancer Patients?
Clinical Cancer Drugs Editorial Nutritional Therapy in Metabolic Syndrome
Current Vascular Pharmacology Heterocyclic Compounds: Effective α-Amylase and α-Glucosidase Inhibitors
Current Topics in Medicinal Chemistry Prediction of Inhibition Activity of BET Bromodomain Inhibitors using Grid Search-Based Extreme Learning Machine and Molecular Docking
Letters in Drug Design & Discovery Drugs and Foods for Chronic Subclinical Inflammation in Humans
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Iron Deficiency: The Hidden Miscreant in Inflammatory Bowel Disease
Current Drug Targets Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy
Current Cancer Therapy Reviews Immunotherapy and Cancer Vaccines in the Management of Breast Cancer
Current Pharmaceutical Design Chelating Agents for the Treatment of Systemic Iron Overload
Current Medicinal Chemistry Glucocorticoid Receptors and Bone
Current Pharmaceutical Design Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer
Current Medicinal Chemistry Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Comparison of Paraben Stability in Human and Rat Skin
Drug Metabolism Letters Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy